Abbreviated Company Accounts - ORALGENICS LIMITED

Abbreviated Company Accounts - ORALGENICS LIMITED


Registered Number 06396414

ORALGENICS LIMITED

Abbreviated Accounts

31 March 2014

ORALGENICS LIMITED Registered Number 06396414

Abbreviated Balance Sheet as at 31 March 2014

Notes 2014 2013
£ £
Fixed assets
Tangible assets 2 1,118 1,490
1,118 1,490
Current assets
Debtors 21,465 21,465
Cash at bank and in hand 5,012 4,193
26,477 25,658
Creditors: amounts falling due within one year (27,000) (11,947)
Net current assets (liabilities) (523) 13,711
Total assets less current liabilities 595 15,201
Total net assets (liabilities) 595 15,201
Capital and reserves
Called up share capital 3 100 100
Profit and loss account 495 15,101
Shareholders' funds 595 15,201
  • For the year ending 31 March 2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 16 December 2014

And signed on their behalf by:
N Dewani, Director

ORALGENICS LIMITED Registered Number 06396414

Notes to the Abbreviated Accounts for the period ended 31 March 2014

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

2Tangible fixed assets
£
Cost
At 1 April 2013 5,258
Additions -
Disposals -
Revaluations -
Transfers -
At 31 March 2014 5,258
Depreciation
At 1 April 2013 3,768
Charge for the year 372
On disposals -
At 31 March 2014 4,140
Net book values
At 31 March 2014 1,118
At 31 March 2013 1,490
3Called Up Share Capital
Allotted, called up and fully paid:
2014
£
2013
£
100 Ordinary shares of £1 each 100 100